EUCTR2004-001927-39-IT进行中（未招募）不适用
A PHASE II, MULTICENTER, UNCONTROLLED, OPEN STUDY IN PATIENTS WITH CHRONIC HEPATITIS C WHO ARE INTOLERANT TO INTERFERONS THERAPYTO EVALUATE THE SAFETY AND EFFICACY OF A TREATMENT WITH THYMOSIN ALPHA 1 PLUS RIBAVIRIN.
SIGMA-TA0 个研究点开始时间: 2005年3月4日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A clinical trial of NOX-A12 in patients with chronic lymphocytic leukemia who have been previously treated and who will be receiving bendamustine and rituximab treatmentRelapsed chronic lymphocytic leukemiaMedDRA version: 14.1Level: PTClassification code 10008958Term: Chronic lymphocytic leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-004672-11-DEOXXON Pharma AG33
进行中（未招募）
1 期
A multi-centre, open label, uncontrolled, Phase IIa clinical trial evaluating the safety and efficacy of NOX-A12 in combination with a background therapy of bendamustine and rituximab (BR) in previously treated patients with chronic lymphocytic leukemia (CLL) - NOX-A12 with a background therapy of bendamustine and rituximab in CRelapsed chronic lymphocytic leukemiaMedDRA version: 14.1Level: PTClassification code 10008958Term: Chronic lymphocytic leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-004672-11-ITOXXON PHARMA AG28
进行中（未招募）
1 期
A clinical trial of NOX-A12 in patients with chronic lymphocytic leukemia who have been previously treated and who will be receiving bendamustine and rituximab treatmentEUCTR2011-004672-11-BEOXXON Pharma AG33
进行中（未招募）
1 期
A clinical trial of NOX-A12 in patients with chronic lymphocytic leukemia who have been previously treated and who will be receiving bendamustine and rituximab treatmentEUCTR2011-004672-11-ATOXXON Pharma AG33
进行中（未招募）
不适用
A clinical trial of NOX-A12 in patients with mutiple myeloma who have previously been treated and who will be receiving bortezomib and dexamethasone treatment.EUCTR2011-004651-40-ATOXXON Pharma AG28